Capturing a novel metastable polymorph of the anticancer drug gefitinib

dc.contributor.author	Thorat, Shridhar H.	en_US
dc.contributor.author	Patwadkar, Manjusha V.	en_US
dc.contributor.author	Gonnade, Rajesh G.	en_US
dc.contributor.author	VAIDHYANATHAN, RAMANATHAN	en_US
dc.date.accessioned	2020-10-20T07:06:50Z
dc.date.available	2020-10-20T07:06:50Z
dc.date.issued	2014-10	en_US
dc.identifier.citation	Crystengcomm, 16(37), 8638-8641.	en_US
dc.identifier.issn	1466-8033	en_US
dc.identifier.uri	http://dr.iiserpune.ac.in:8080/xmlui/handle/123456789/5210
dc.identifier.uri	https://doi.org/10.1039/C4CE01446D	en_US
dc.description.abstract	Gefitinib, a life-extending anticancer drug, exhibits solvent-mediated conformational polymorphism to yield stable (form I) and novel metastable (form II) polymorphs. Crystal structure analysis revealed 3D isostructurality in the molecular organization of the polymorphs, and the metastable polymorph undergoes a crystal-to-crystal thermal phase transition to the stable polymorph.	en_US
dc.language.iso	en	en_US
dc.publisher	Royal Society of Chemistry	en_US
dc.subject	Chemistry	en_US
dc.subject	2014	en_US
dc.title	Capturing a novel metastable polymorph of the anticancer drug gefitinib	en_US
dc.type	Article	en_US
dc.contributor.department	Dept. of Chemistry	en_US
dc.identifier.sourcetitle	Crystengcomm	en_US
dc.publication.originofpublisher	Foreign	en_US